Dr Jamie Agisheva, ND | |
18516 101st Ave Ne Ste 3, Bothell, WA 98011-3874 | |
(425) 492-0082 | |
(425) 250-8499 |
Full Name | Dr Jamie Agisheva |
---|---|
Gender | Female |
Speciality | Naturopath |
Location | 18516 101st Ave Ne Ste 3, Bothell, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578119160 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Jamie Agisheva, ND 14148 74th Pl Ne Apt D, Kirkland, WA 98034-4948 Ph: (818) 425-1027 | Dr Jamie Agisheva, ND 18516 101st Ave Ne Ste 3, Bothell, WA 98011-3874 Ph: (425) 492-0082 |
News Archive
Dr. Richard Dolinar, chairman of the Alliance for Safe Biologic Medicines (Alliance) outlined five areas of concern that the U.S. Food and Drug Administration (FDA) should resolve before they allow biosimilar medications on the U.S. drug market in prepared testimony for the FDA's May 11th public hearing. The event addressed the FDA's recent draft guidelines for the development of biosimilar products.
Milestone Scientific Inc., the recognized leader in advanced, computer controlled drug delivery technologies, and Ordway Research Institute, a leading research and drug development organization, have agreed to develop drug formulations for precise targeted delivery of drugs to affected body parts, organs and cancerous tissue through Milestone's patented CompuFlo injection technology.
RemedyMD (www.RemedyMD.com), the leading provider of Disease Registry software, today announced the first nationwide Pediatric Diabetes Registry. The new registry was developed to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
The public, including parents of babies with severe heart defects, are invited to submit questions for inclusion in a tweet chat about surgical approaches for heart defects from noon-2 p.m. Wednesday, Jan. 20 on Twitter.
› Verified 5 days ago